Latest information on COVID-19
Support teaching, research, and patient care.
Gill Bejerano holds a B.Sc. In Mathematics, Physics and Computer Science, and a Ph.D in Computer Science (Machine Learning applications in Biology) from Hebrew University of Jerusalem. Gill got into genomics in 2003, started a wet lab in 2007, began analyzing patient genomes and medical records in 2014, got into cryptogenomics in 2017 and has become very interested in healthcare economics and patient risk management in 2021. He is recognized by multiple academic awards including two best paper and tomorrow's PI awards, Mallinckrodt, Sloan, Human Frontiers, Searle, Okawa, David and Lucile Packard, Microsoft and Sony Scholar awards. Gill has trained, collaborated and advised computational scientists, experimentalists, clinicians, and MBAs and has helped both start-ups and Fortune 500 companies.
The Bejerano lab interests evolve continuously. As of 2021 they span data science, genomic variants of large effect, cryptogenomics, electronic health records and healthcare economics. We are venturing into: <br/>1. Managing patient risk using machine learning.<br/>2. Understanding the flow of money in the US healthcare system (for nothing matters more). <br/>We have done seminal work and continue to play an active role in:<br/>3. Automating monogenic patient diagnosis (to the dismay of experts in the field).<br/>4. Cryptogenomics to bridge medical silos.<br/>5. Cryptogenetics to debate social injustice. <br/>6. The genomic signatures of independent divergent and convergent trait evolution in mammals.<br/>7. The beyond-reach logic of human gene regulation.<br/>8. The mysterious reasons for sequence ultraconservation.